Here are examples of sessions featured in SXSW’s psychedelics track:FDA Approved Love? Exploring MDMA’s Psychedelic Journey With the Food and Drug Administration on pace to approve therapeutic MDMA as soon as next year, this panel—featuring Rick Doblin and Julie Holland of the Multidisciplinary Association for Psychedelic Studies (MAPS)—looks at how MDMA went “from the dance floor to late-state clinical trials to…potentially the therapist’s couch.” Finding Balance: Your Relationship with Psychoactive Plants In this panel, Amanda Reiman, a public health researcher and harm reduction advocate who’s spent more than two decades studying cannabis policy, delves into how to develop mindful, healthy relationships with psychedelics, marijuana and other psychoactive plants. The session will also include tips on what healthy consumption patterns look like and what to do if one’s consumption becomes dangerous or problematic.
MDMA Saved My Life: Psychedelics and Healing From Sexual Trauma This panel, featuring therapists along with representatives from the Urban Indigenous Collective and The Phoenix Project, “explores personal journeys of healing from sexual abuse and the pivotal role psychedelics play in facilitating that process.” The Bar’s New Top Shelf: Elevation Over Inebriation Acknowledging that “public demand is rising for alcohol substitutes that provide an experience,” this panel looks at the legal status of all sorts of other consciousness-altering substances, including kanna, kava, psilocybin, kratom, coca, damiana, mescaline, cannabis, ketamine GHB and other compounds. “For centuries, humans have safely used natural substances to unwind and socialize, but societal norms and outdated laws make competing with alcohol a challenge,” a description says. “What will it take to create a post-alcohol world?” Man vs. Nature: The Commercialization of Psilocybin Medicine Researchers and experts sit down to discuss the legal and commercial implications of psilocybin research and legalization as part of this panel, which features researcher Sue Sisley and Shawn Hauser, a partner at the law firm Vicente LLP who works with psychedelics and cannabis businesses. Speakers will explain why nearly all clinical studies around psilocybin use synthetic versions of the substance even though it’s made naturally by various mushrooms, and why some researchers are fighting to study natural products. Psychedelic Leadership and Systems Change From Steve Jobs to former Twitter head Jack Dorsey to Elon Musk, business leaders in prominent positions have increasingly embraced altered states of consciousness. This panel, featuring a Google vice president along with members of the Psychedelic Leadership Company and MAPS Public Benefit Corporation, asks, “Can psychedelic experiences improve leadership by fostering qualities such as creativity and open-mindedness? Can they help us live in balance by encouraging prosocial behavior and empathy? Or are they likely to amplify narcissism and extractive behaviors?”
I am thrilled to announce that I will be presenting at @sxsw in the Psychedelics Track! Since I founded @PlantsPersonal in 2020, my goal has been to help people make safe decisions about their use of cannabis and psychedelics. I can't wait to address this in my session: Finding…— Dr. Amanda (@AmandaReiman) November 1, 2023
We're back with another round of sessions for the #SXSW Conference! Explore 450+ community-sourced sessions across 24 tracks. Dive into the schedule and start planning your SX adventure today. https://t.co/ZICg1kHemS— SXSW (@sxsw) November 1, 2023